REV-ERB comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Updated 2025-12-15. Numbers and descriptions here follow the published literature rather than marketing material.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ, also called NR1D1 and NR1D2. These receptors help regulate circadian rhythms and metabolic gene programs. The compound was developed for laboratory research, not as an approved therapeutic. Its identity is distinct from steroid hormones and selective androgen receptor modulators. Scientific interest centers on how REV-ERB activation changes gene expression in cells and animal models.
At the molecular level, SR9009 binds the ligand-binding domain of REV-ERB and strengthens recruitment of corepressor proteins such as NCoR and HDAC3. This increases repression of target genes, including Bmal1 and other clock-controlled and metabolic genes. In rodent studies, such changes have been linked to altered lipid handling, glucose metabolism, and energy expenditure. The precise chain of events between receptor binding and whole-body effects remains an active area of research. Findings in animals do not automatically translate to humans.
Analytical identification of SR9009 typically relies on liquid chromatography coupled with tandem mass spectrometry. In biological samples, researchers first separate the compound from matrix components using protein precipitation, liquid-liquid extraction, or solid-phase extraction. High-performance liquid chromatography with ultraviolet detection and nuclear magnetic resonance spectroscopy can support structural confirmation of reference materials. Because SR9009 is a small, relatively lipophilic molecule, reverse-phase columns and acidic mobile phases are common. Laboratories often include isotope-labeled internal standards to improve quantification and to correct for ion suppression.
Stability depends on physical form, temperature, light exposure, and solvent. Solid SR9009 is generally stored cold and dry, with protection from light to limit degradation. Dimethyl sulfoxide stocks are common for laboratory work, but repeated freeze-thaw cycles can reduce compound integrity. Aqueous solutions may be less stable than organic stocks, and the ethyl ester in the structure can be susceptible to hydrolysis under certain conditions. Researchers typically validate storage conditions and recheck purity before quantitative experiments, especially when using archived material.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Synthetic small molecule | Studied as a REV-ERB agonist |
| Molecular formula | C20H24ClN3O4S | Reported for the neutral compound |
| Appearance | Off-white to pale yellow solid | Typical research-grade material |
| Solubility | Sparingly soluble in water | Soluble in solvents such as DMSO |
| Common synonyms | SR9009; Stenabolic | Stenabolic is an informal alias |
Storage conditions for research-grade SR9009 generally involve a freezer at approximately minus twenty degrees Celsius, sometimes lower for long-term preservation. Containers should remain tightly closed and protected from light. Desiccants may be used to limit moisture uptake. Solutions are often stored in aliquots to avoid repeated warming and cooling. Stability data for the compound under various conditions are limited, so laboratories typically follow supplier recommendations and verify performance through periodic analytical checks rather than assuming indefinite stability.
Identity and purity testing for SR9009 commonly uses liquid chromatography coupled with tandem mass spectrometry. This method separates the compound from matrix components and detects it by mass-to-charge transitions, providing sensitive and specific confirmation. Nuclear magnetic resonance spectroscopy can support structural identification, while high-performance liquid chromatography with ultraviolet detection may estimate purity. Because online products labeled as SR9009 may contain other substances or no active compound at all, independent verification is important in research settings. Certificates of analysis are useful but not a substitute for in-house testing.
== See also == Alpha toxin Pathology Lysosomal acid lipase deficiency Peripheral membrane proteins Phospholipase A Phospholipase C Triglyceride lipase Phospholipase A2 Outer membrane phospholipase A1 Patatin-like phospholipase
=== Rifles === Lee-Enfield No. 4 – Main service rifle until the adoption of the L1A1 SLR in 1954. No. 4 Mk 2 model manufactured until 1957. A 7.62mm NATO conversion programme was attempted in the 1960s but proved abortive. De Lisle carbine - Retired in 1954 in favour of focusing on suppressed Sten variants. EM-2 rifle – Experimental rifle adopted very briefly in 1951. FN FAL – Original Belgian version adopted for troop trials as X8E1-E5, with E1 and E5 models still being in the supply chain as of January 1959. Domestically produced L1A1 Self-Loading Rifle version used as main service rifle from 1954 to 1994. Argentinian-issue FAL Paras that had been captured during the Falklands War were used by the SAS in Northern Ireland until the development of the HK G3KA4. Colt AR-15, M16 rifle - Trialled in February 1964 and adopted in April 1965. Used in tropical conditions. Also issued to special forces, Royal Marines Mountain and Arctic Warfare Cadre, and close observation platoons. Heckler & Koch G3 - Special forces issue. L85A1 rifle – Initial batches issued in 1985; frontline Army units, Royal Marines, and RAF Regiment scheduled to be fully equipped by 1987, rest of regular Army scheduled to be fully equipped by 1990. HK53 - used by Royal Military Police Close Protection Units (RMP CPU), 14 Intelligence Company, and special forces.
For services to Health Care. Arthur Derek Hill. For services to Art. Jenny Hughes, , Chairman, Riverside Mental Health NHS Trust. For services to Health. Kenneth Wesley Jarrold, Director of Human and Corporate Resources, NHS Executive, Department of Health. George MacDonald Kennedy, Chairman, Smiths Industries Medical Systems. For services to the Health Care Industry and to Export. Cecil Gordon Knight, , Headteacher, Small Heath School, Birmingham. For services to Education. Simon Timothy Lee. For political service. Thomas Peter Ruffell Laslett. For services to the Cambridge Group for the History of Population and Social Structure. Robert Noyes Lawton. For services to Agriculture in Wessex. Martyn John Dudley Lewis, Chair, Drive for Youth and Youthnet UK. For services to Young People and to the Hospice Movement. Francis David Lindley Loy, lately Chairman, Provincial Stipendiary Magistrates' Association. John Lumsden, Chief Executive, Motherwell Bridge Group. For services to the Engineering Industry. Thomas George Mackey. For services to Urban Regeneration. Colin Barry Manchip, lately Director, Immigration Service (Enforcement), Home Office. Brenda Mary McLaughlin. For services to the community and to Health Care. Elizabeth Mary McLoughlin, Head of Civilian Management (Policy), Ministry of Defence. James David Frederick Miller, Chairman, Scottish Qualification Authority. For services to Education. Dominic Charles Bernard Morris, lately Deputy Head, Policy Unit, 10 Downing Street. Richard Brian Mouatt, lately Chief Dental Officer, Department of Health.
Sources: en.wikipedia.org
== Reactions == Thionyl chloride is mainly used in the industrial production of organochlorine compounds, which are often intermediates in pharmaceuticals and agrochemicals. It usually is preferred over other reagents, such as phosphorus pentachloride, as its by-products (HCl and SO2) are gaseous, which simplifies purification of the product. Many of the products of thionyl chloride are themselves highly reactive and as such it is involved in a wide range of reactions.
==== Step 2: Elongation ==== Following initiation, the polypeptide chain is extended via anticodon:codon interactions, with the ribosome adding amino acids to the polypeptide chain one at a time. The following steps must occur to ensure the correct addition of amino acids: 1. The binding of the correct tRNA into the A site of the ribosome 2. The formation of a peptide bond between the tRNA in the A site and the polypeptide chain attached to the tRNA in the P site 3. Translocation or advancement of the tRNA-mRNA complex by three nucleotides Translocation "kicks off" the tRNA at the E site and shifts the tRNA from the A site into the P site, leaving the A site free for an incoming tRNA to add another amino acid.
== History == It was discovered through the use of high-throughput screening of 25,000 compounds. Toltrazuril and ponazuril (ACD855), two veterinary antiparasitic agents, were identified as possessing Trk-potentiating activity with this screen in 2013. ACD856 was derived via structural optimization of these compounds. In the case of ponazuril, this drug was said to have had too long of an elimination half-life to allow for development for use in humans. ACD856 was first described in the scientific literature by 2021.
== Transmission == The feline panleukopenia virus is considered ubiquitous, meaning it is in virtually every place that is not regularly disinfected. The infection is highly contagious among unvaccinated cats. Antibodies against FPLV, produced by the adaptive immune system, play an important role in the feline response to the virus. Maternally-derived antibodies (MDA) efficiently protect kittens from fatal infection. This passively acquired immunity is later replaced by an active immune response obtained by vaccination or as a consequence of a natural infection. In kittens, the period of greatest susceptibility to infection is when maternal antibodies are absent, or waning, and vaccine-induced immunity has not yet fully developed. Free-roaming cats are thought to be exposed to the virus during their first year of life. Those that develop a subclinical infection or survive acute illness mount a robust, long-lasting, protective immune response. An infected cat sheds large amounts of virus in all body secretions including feces, vomit, urine, saliva, and mucus during the acute phase of illness. It can continue to shed the virus for as long as six weeks after recovery. Subclinically ill cats can also shed the virus in body secretions. The virus can be carried or transferred on an infected object (such as bedding, food dishes, fur) or by other animals, fleas, and humans (see: fomites). It persists long after evidence of the original body secretion has faded away, and can be transported long distances.
Sources: en.wikipedia.org
William DeGrado (born 12 September 1955) is a professor at the University of California, San Francisco, where he is the Toby Herfindal Presidential Professor of Entrepreneurship and Innovation in the Department of Pharmaceutical Chemistry. As an early pioneer of protein design, he coined the term de novo protein design. He is also active in discovery of small molecule drugs for a variety of human diseases. He is a member of the U.S. National Academy of Sciences (1999), American Academy of Arts & Sciences (1997) and National Academy of Inventors. He also is a scientific cofounder of Pliant therapeutics.
Selective estrogen receptor modulators (SERMs) are an important class of hormonal therapy agents which act as antagonists of the estrogen receptor and are used primarily for the treatment and chemoprevention of breast cancer. Some members of this family, such as tamoxifen, are actually partial agonists, which can actually increase estrogen receptor signalling in some tissues, such as the endometrium. Tamoxifen is currently first-line treatment for nearly all pre-menopausal women with hormone receptor-positive breast cancer. Raloxifene is another partial agonist SERM which does not seem to promote endometrial cancer, and is used primarily for chemoprevention of breast cancer in high-risk individuals, as well as to prevent osteoporosis. Toremifene and fulvestrant are SERMs with little or no agonist activity, and are used for treatment of metastatic breast cancer.
German South West Africa was established in 1884. After World War I, the League of Nations gave South West Africa, formerly a German colony, to the United Kingdom as a mandate under the administration of South Africa. When the National Party won the 1948 election in South Africa and subsequently introduced apartheid legislation, these laws were also applied to South West Africa which was considered the de facto fifth province of South Africa. SWAPO was founded on 19 April 1960 as the successor of the Ovamboland People's Organization. Leaders renamed the party to show that it represented all Namibians. But, the organisation had its base among the Ovambo people of northern Namibia, who constituted nearly half the total population.
Synapse and dendritic spine growth may be disrupted in autism due to impaired neurexin–neuroligin cell-adhesion signaling or dysregulated synthesis of synaptic proteins. Disrupted synaptic development may also contribute to epilepsy, which may explain why the two conditions are associated. Studies have shown that imbalances between excitation and inhibition (EI) in brain circuitry is the primary cause of synaptic dysfunction in autism. Major Histocompatibility Class I (MHCI) antigens and inflammatory cytokines may be responsible for regulating the EI balance by impacting synapse development and plasticity. Neurotransmitters such as serotonin, dopamine, and glutamate have been implicated in autism. The dysregulation of neurotransmitters and neuropeptides can contribute to pathophysiology and symptoms of autism. Fragile X, the most common genetic cause of autism, is linked to dysfunction of group I metabotropic glutamate receptors (mGluR), leading some to consider their potential role in autism.
== See also == 2015 state visit by Xi Jinping to the United States APEC China 2026 China–United States relations List of international presidential trips made by Donald Trump 2026 visit by Vladimir Putin to China
Sources: en.wikipedia.org
SR9009 is a synthetic research compound that activates the REV-ERBα and REV-ERBβ nuclear receptors. It is not an approved drug and has no established human therapeutic use. Most published biological data come from cell and rodent studies.
No. SR9009 is frequently mislabeled as a SARM in online discussions, but it does not target androgen receptors. Its known mechanism involves REV-ERB nuclear receptors and circadian-metabolic gene regulation.
Human clinical data are very limited. There is no approved human use, and safety and efficacy in people are not established. Most evidence comes from preclinical models, so effects observed in animals may not apply to humans.
The most common approach is liquid chromatography-tandem mass spectrometry, often after extraction from blood, urine, or tissue. Ultraviolet detection and nuclear magnetic resonance spectroscopy are used mainly for reference material characterization. Isotope-labeled internal standards improve accuracy.